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Background: Hematology analyzers may ineffectively recognize abnormal cells, and manual differential counts may be imprecise 
for leukopenic samples. We evaluated the efficacy of the Hematoflow method for determining the leukocyte differential in leuko-
penic samples and compared this method with the manual differential method.
Methods: We selected 249 blood samples from 167 patients with leukopenia (WBC counts, 500–2,000/μL) for analysis in this study. 
The EDTA-anticoagulated blood samples were analyzed using an automatic blood cell counter (DxH800; Beckman Coulter, USA) 
and flow cytometry (FC 500; Beckman Coulter) by using Cytodiff reagent and analysis software (Beckman Coulter). Hematoflow re-
sults were selected or calculated from DxH800 and Cytodiff results. Two trained pathologists performed a manual differential 
count by counting 50–100 cells.
Results: The precision of the Hematoflow method was superior to that of the manual method in counting 5 leukocyte subpopula-
tions, immature granulocytes (IGs), and blasts. Blasts were detected in all 45 cases (100%) by Hematoflow. The correlation of the 
Cytodiff blast count to the reference count was high (r = 0.8325). For all other cell populations, the correlation of the Hematoflow 
results with the reference count was stronger than that of the other manual counts with the reference count.
Conclusions: The Hematoflow differential counting method is more reproducible and sensitive than manual counting, and is rela-
tively easy to perform. In particular, this method detected leukemic blasts more sensitively than manual differential counts. The 
Hematoflow method is a very useful supplement to automated cell counting.
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INTRODUCTION
The majority of hematology cell analyzers are useful for 
quantitative enumeration of leukocytes, but they are rela-
tively ineffective in qualitative recognition of abnormal cells 
[1]. Hematology cell analyzers can detect abnormal differ-
ential patterns or abnormal cells and “flag” them. However, 
in most cases, the presence of abnormal cells must be estab-
lished by microscopic examination of blood smears [2, 3]. 
Manual differential counting is the reference method for 
white blood cell (WBC) differential counts, but it is labor-
intensive and time-consuming with variable reproducibility 
and cannot distinguish between cells on the basis of qualita-
tive differences [4]. The incidence of leukopenia has mark-
edly increased in hospital laboratories in recent years, largely 
due to an increase in the number of cancer and leukemia 
patients receiving chemotherapy or radiotherapy [5, 6]. 
Manual differential counts of leukopenic samples are noto-
riously imprecise, which can be attributed to the insufficient 
number of countable cells in these samples. Further, the 
classification of cells in these samples is generally both diffi-
cult and time-intensive [7]. Rapid and accurate confirma-
tion of abnormal cells by flow cytometry is required to 
reach a final diagnostic conclusion.
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of cells is the identification of cell types that cannot be iden-
tified by the current morphologic differentiation techniques 
[8-10]. Recently, the Hematoflow method was introduced 
(Beckman Coulter, Miami, FL, USA). This method com-
bines an automatic hematology cell analyzer (DxH800; 
Beckman Coulter), flow cytometry (FC500; Beckman 
Coulter), and Cytodiff (5-colors 6-antibodies flow cytome-
try using premixed reagent & analysis software; Beckman 
Coulter) [11]. In this study, we evaluated the efficacy of de-
termining the leukocyte differential by using the Hemato-
flow method in leukopenic samples and compared it with 
the manual differential method.
MATERIALS AND METHODS
1. Patients and samples
Two hundred forty-nine EDTA-anticoagulated blood 
samples from 167 patients (88 males and 79 females; age, 
1-75 yr; mean age, 38 yr) who had a WBC count of 500-
2,000/μL in routine CBC were selected for analysis. The pa-
tients’ diagnoses were as follows: 65 cases of AML, 34 cases 
of ALL, 15 cases of aplastic anemia, 14 cases of malignant 
lymphomas, 10 cases of solid tumors, 10 cases of MDS, 1 
case of paroxysmal nocturnal hemoglobinuria (PNH), and 
18 cases of other hematologic diseases. Blasts were discov-
ered during the reference count in 36 of 125 AML samples 
and 9 of 46 ALL samples. None of the samples from MDS 
patients harbored blasts. This study was approved by the In-
stitutional Review Board of the Catholic University of Ko-
rea College of Medicine.
2. Analysis using Hematoflow
Blood samples were analyzed with an automatic blood 
cell analyzer (DxH800) for routine CBC, and 8,920 leuko-
cytes were counted per sample. We then analyzed the same 
blood samples for determining the leukocyte differential 
using flow cytometry (FC500) in conjunction with a pre-
mixed Cytodiff reagent and analysis software. The Cytodiff 
panel included CD36-FITC, CD2-PE, CD294-PE, CD19-
ECD, CD16-PC5, and CD45-PC7 antibodies. The leuko-
cytes were differentiated into 16 cell populations (B-lym-
phocytes, CD16- T-lymphocytes, CD16+ T and NK cells, T 
and NK lymphocytes, total lymphocytes, CD16 monocytes, 
CD16+ monocytes, total monocytes, immature granulo-
cytes [IGs], total eosinophils, mature neutrophils, total neu-
trophils, B blasts, T blasts, non-B-non-T blasts, and total 
basophils; Fig. 1). Analysis procedures were conducted in 
accordance with the manufacturer’s manual. In brief, 100 
μL of whole blood samples was mixed with 10 μL of Cyto-
diff reagent and incubated for 20 min at room temperature. 
Red blood cells were broken down with lysing solution 
(Versalyse solution; Beckman Coulter) for 15 min. Without 
washing, 10,000 cells were collected using a flow cytometer 
(FC500) and the Cytodiff results were analyzed automati-
cally by the analysis software. The analysis software is self-
gating and separates populations by automatic logic path-
ways. As instructed by the manual, the gates were only ad-
justed in cases of large debris contamination or incomplete 
separation of basophils and myeloblasts. All samples were 
analyzed in duplicate. All the Hematoflow results, except 
eosinophil and IG counts, were obtained using the Cytodiff 
reagent. We used the DxH800 eosinophil count as the He-
matoflow eosinophil count because the DxH800 eosinophil 
count was more highly correlated to the reference eosino-
phil count than that obtained using Cytodiff. Hematoflow 
IG count was calculated by subtracting the DxH800 eosino-
phil count from the sum of the Cytodiff IG count and Cyto-
diff eosinophil count, because the IGs and eosinophils were 
not well separated in Cytodiff counting.
3. Manual differential counting
A trained hematology technician and a hematopatholo-
gist did manual differential counts by counting 50-100 cells. 
We selected the manual counts done by hematopathologist 
as reference counts. Manual counting may increase the 
sampling error rate [7]. We added the number of metamy-
elocytes, myelocytes, and promyelocytes to obtain the num-
ber of IGs in the manual count. 
4. Statistical analysis
We used MedCalc v11.2 (Mariakerke, Belgium) and Ex-
cel 2007 (Redmond, WA, USA) to perform Fisher’s F test 
for analysis of repeatability and Pearson’s correlation test for 
correlation analysis.
RESULTS
1. Analysis time and gate adjustment
The average acquisition time for 20 leukopenic samples 
(10,000 events) by Hematoflow was approximately 90 min, 
including incubation and reading time, and the active labor 
time was 15 min. In Cytodiff counting, gates were adjusted 
in 19 out of 247 cases (7.7%). In 2 cases, adjustments were 
made because of large debris contamination and in 17 
cases, they were made because of incomplete separation be-
tween basophils and myeloblasts. In both cases of large de-
bris contamination, the contamination was only observed 
during the first run, but not during the second run.Jo Y, et al.  •  Hematoflow Method for Leukocyte Differential
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2. Leukocyte subpopulations
The repeatability of the Hematoflow method in counting 
5 leukocyte subpopulations, IGs, and blasts was superior to 
that of the manual differential method (Table 1). The mean 
differences between repeated Cytodiff counts were 1.24± 
2.70%, 0.98±1.53%, and 0.85±1.19% for neutrophils, lym-
phocytes and monocytes, respectively. When counted man-
ually, the mean differences between repeated counts were 
much higher (5.4±5.8%, 6.1±5.6%, and 3.4±4.7%, respec-
tively, P<0.001). Cytodiff counts for neutrophils, lympho-
cytes, and monocytes were highly correlated with the refer-
ence counts (r=0.9704, r=0.9724, and r=0.8981, respec-
tively).
The mean difference between repeated eosinophil assays 
Fig. 1. An example of CytoDiff results. Sixteen cell populations are displayed in different colors with complicated gates.134     www.kjlm.org
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by the Cytodiff count was 0.48±2.33% and was lower than 
that in the case of manual counting (0.7±1.4%, P<0.001). 
However, in the case of the eosinophil counts, the correla-
tion of the reference count with the DxH800 count (r=0. 
8766) was higher than that with the manual count (r=0. 
8222) or the Cytodiff count (r=0.6671). Therefore, eosino-
phil counting by DxH800 was used as the eosinophil count 
in Hematoflow.
The distinction between basophil and non-B-non-T blast 
populations was not particularly clear. In such cases, the cell 
populations were considered to represent either basophils 
or non-B-non-T blasts on the basis of the median fluores-
cence level (<3.5: non-B-non-T blasts, ≥3.5: basophils). 
The mean difference between repeated basophil assays by 
Cytodiff count was 0.32±0.61% and was slightly lower than 
that in the case of manual counting (0.6±1.6%, P<0.001). 
The correlation of the basophil count to the reference count 
was high in the case of Cytodiff count (r=0.8727) and was 
higher than that for manual counting (r=0.7886). DxH800 
basophil counts, however, were poorly correlated with the 
reference count (r=0.0389; Table 1). When non-B-non-T 
blasts were not present, we obtained clear basophil signals 
in Cytodiff (Fig. 2).
3. Blasts
Blasts were detected in all 45 cases (100%) by Hemato-
flow method and in 17 cases (37.8%) by manual counting 
method (Figs. 2, 3). The mean difference between repeated 
Table 1. Results of repeatability and correlation of Hematoflow differential count to reference count
Cell population
Difference of repeated assay (F-test)
Correlation to reference  count Differences between repeated assays (mean±SD)
Manual Cytodiff P value
Neutrophil 5.4±5.8 1.24±2.70 <0.001 DxH800 0.9463 B lymphocyte 0.21±0.27
Cytodiff 0.9704
Lymphocyte 6.1±5.6 0.98±1.53 <0.001 DxH800 0.9618 T lymphocyte CD16- 1.28±3.65
Cytodiff 0.9724
Monocyte 3.4±4.7 0.85±1.19 <0.001 DxH800 0.5817 T & NK CD16+ 0.55±2.27
Cytodiff 0.8981
Eosinophil 0.7±1.4 0.48±2.33 <0.001 DxH800 0.8766 Total T & NK 1.51±5.09
Cytodiff 0.6671
Basophil 0.6±1.6 0.32±0.61 <0.001 DxH800 0.0389 Monocyte CD16- 1.09±4.31
Cytodiff 0.8727
IG* 0.8±3.4 0.71±2.16 <0.001 Cytodiff 0.3576 Monocyte CD16+ 0.36±0.60
Hematoflow
† 0.3639
Blast 1.7±6.6 0.65±1.99 <0.001 Cytodiff 0.8325
*immature granulocytes - promyelocytes, myelocytes, metamyelocytes; 
†(Cytodiff IG + Cytodiff eosinophil) − DxH800 eosinophil.
Fig. 2. (A) Non-B-non-T blasts (red) and basophils (black) using the CD2+CD294 expression pattern. (B) The basophils show higher fluorescence than the non-B-
non-T blasts.
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blast assays by Hematoflow count was 0.65±1.99% and was 
lower than that obtained by manual counts (1.7±6.6%, 
P<0.001). The correlation of the blast count to the refer-
ence count was similar for the Cytodiff count (r=0.8325) 
and the manual count (r=0.8627). 
4. Immature Granulocytes
The Hematoflow IG count correlated more strongly with 
the reference count than the Cytodiff IG count (Table 1). 
The mean difference between repeated IG assays by Hema-
toflow count was 0.71±2.16% and was slightly lower than 
that in the case of the manual count (0.8±3.4%, P<0.001). 
The correlation of the Hematoflow IG count to the reference 
count (r=0.3639) was higher than that of the manual count 
(r=0.2170). Type III granulocytes were sometimes counted 
as IGs, especially in 1 PNH case, because the type III neu-
trophils are CD16 negative cells (Fig. 4).
DISCUSSION
The slides from leukopenic samples often do not have a 
sufficient number of cells to count, and it is difficult to ob-
serve a cell distribution in the ideal zone. The majority of 
leukopenic samples are collected from patients receiving 
chemotherapy and/or radiotherapy, which can cause altered 
morphologies of the cells [12]. This makes the manual dif-
ferential count of leukopenic samples more difficult. How-
ever, the absolute neutrophil count (ANC) or presence of 
blasts is critically important for patients. The average time 
required for the Hematoflow counts of 20 leukopenic sam-
ples (10,000 events) was approximately 90 min, including 
incubation and reading time, and the active labor time was 
Fig. 3. (A) B lymphoblasts (brown) and B lymphocytes (sky-blue) using the CD19+ cell population are differentiated by CD45 expression level. (B) Because the 
promyelocytes are included in IGs, acute promyelocytic leukemic cells are counted as IGs (purple).
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Fig. 4. (A) Paroxysmal nocturnal hemoglobinuria (PNH) type III granulocytes are counted as IGs in samples from PNH patients. (B) A similar proportion of mature 
neutrophils from the same patient are FLAER-negative (type III, P4). 136     www.kjlm.org
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only 15 min (less than 1 min per case). Manual differential 
counting requires slide making, staining, drying, and mi-
croscopic examination. It is very time-consuming and it is 
difficult to conduct differential counts of leukopenic sam-
ples. The throughput of manual differential counting of leu-
kopenic samples depends on the leukocyte count, skill of 
the personnel, and active labor time, but it is usually more 
than 5 min per sample. Therefore, the throughput of the 
Hematoflow method is acceptable.
Gates were adjusted in 19 of 247 Cytodiff cases (7.7%) 
due to large debris contamination (2 cases) and incomplete 
separation between basophils and myeloblasts (17 cases). 
The 2 cases involving large debris contamination exhibited 
this problem only in the first run, but not in a repeated run. 
Therefore, repeated analysis is recommended when large 
debris is present. As large debris is rarely present in samples 
from non-leukemia patients, these samples do not require 
any additional work. Therefore, this method may prove 
more valuable for non-leukemic patients than for leukemic 
patients. 
The repeatability of the Hematoflow method was superior 
to that of the manual differential counting method in the 
counting of 5 leukocyte subpopulations, IGs, and blasts. Ad-
ditionally, the correlation of counts obtained using the He-
matoflow method to the reference counts was also quite 
good. This means that in leukopenic samples, the leukocyte 
differential obtained using the Hematoflow method is more 
reproducible and sensitive than that obtained using other 
methods, including the manual differential method. In par-
ticular, the mean difference between repeated Cytodiff neu-
trophil assays was far lower than that between repeated 
manual counts. This might facilitate reproducible ANC 
counts in patients with leukopenia. 
The mean difference between repeated monocyte assays 
by Cytodiff count was much lower than that by manual 
counts. The reference monocyte count showed high corre-
lation with the Cytodiff count (r=0.8981), which was much 
higher than that with the DxH800 count (r=0.5817). This 
means that the morphology of other leukocytes in the leu-
kopenic samples could have been seriously altered, possibly 
by processes such as vacuolation, making it difficult to visu-
ally differentiate them from monocytes.
The eosinophil count from DxH800 was superior to that 
of the other methods tested. Hematology cell analyzers are 
quite effective in eosinophil counting [13, 14]. The separa-
tion of IGs and eosinophils by automatic gating in the Cy-
todiff method is not an efficient method for distinguishing 
IGs from eosinophils. Therefore, we recommend using the 
DxH800 eosinophil results and the calculated IG count as 
the Hematoflow values for these cell types.
While other researchers have reported a low correlation 
between the Cytodiff basophil count and reference counts 
[8], we found a high correlation between these counts (r= 
0.8727). This is due to CD2 + CRTH2. The CRTH2 is ex-
pressed in activated T-cells, eosinophils, and basophils. 
Separation between basophils and non-B-non-T blast pop-
ulations was not effective in the Hematoflow method. In 
these cases, the cell populations were counted as either ba-
sophils or non-B-non-T blasts using the median fluores-
cence level (<3.5: non-B-non-T blasts, ≥3.5: basophils). 
Because clear basophil signals were obtained in cases with-
out non-B-non-T blasts, this calculation was not required 
for non-AML samples. The blast-detection rate using He-
matoflow was 100%, which is much higher than the rate 
achievable by microscopic examination. The detection of 
rare blasts in leukemia patients is very important [15]. The 
precision of blast detection by Hematoflow method was su-
perior to that of the manual counting method. The correla-
tion of the blast count by the Hematoflow method to the 
reference count was similar. It may be useful to screen sam-
ples for the presence of blasts using Cytodiff. If blasts are 
detected by Cytodiff, confirmation of the blasts by slide re-
view is recommended, especially in new patients. 
The repeatability of remaining cell population counts was 
excellent when the Hematoflow method was used, even for 
counts made from leukopenic samples. The significance of 
differential counts of subsets of lymphocytes has been well 
established, and each cell population has a distinct clinical 
significance [16-18]. 
Cytodiff categorizes the PNH type III granulocytes as 
IGs, because the type III neutrophils are CD16 negative 
[19]. If a higher than normal Hematoflow IG count is de-
tected in a patient without a reason for the left shift of neu-
trophils, PNH should be suspected.
In this study, we evaluated a new WBC differential me-
thod. The Hematoflow method uses flow cytometry (FC500) 
together with a hematology cell analyzer (DxH800). The 
Hematoflow differential counting method is a more repro-
ducible and sensitive method than manual counting, and is 
relatively easy to perform. In particular, the Hematoflow 
method is much more sensitive than the manual differential 
counting method in the detection of leukemic blasts. The 
Hematoflow method provides more cell population data [11] 
than the manual differential count, including blast lineages. 
In conclusion, the Hematoflow method is very useful in 
supplementing the automated cell counting. The technique 
is expected to be even more useful if data from the hematol-
ogy cell analyzer and flow cytometry can be automatically Jo Y, et al.  •  Hematoflow Method for Leukocyte Differential
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combined, and any required calculations become auto-
mated.
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